Ionescu-Ittu R - Search Results

1

Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.

Guérin A, Chen L, Ionescu-Ittu R, Marynchenko M, Nitulescu R, Hiscock R, Keir C, Wu EQ. Guérin A, et al. Curr Med Res Opin. 2014 Nov;30(11):2317-28. doi: 10.1185/03007995.2014.944973. Epub 2014 Aug 5. Curr Med Res Opin. 2014. PMID: 25025755 Clinical Trial.

2

Comparing nilotinib with dasatinib as second-line therapies in patients with chronic myelogenous leukemia resistant or intolerant to imatinib -- a retrospective chart review analysis.

Griffin JD, Guerin A, Chen L, Macalalad AR, Luo J, Ionescu-Ittu R, Wu EQ. Griffin JD, et al. Curr Med Res Opin. 2013 Jun;29(6):623-31. doi: 10.1185/03007995.2013.789012. Epub 2013 Apr 8. Curr Med Res Opin. 2013. PMID: 23517347

3

Distribution and drivers of costs in type 2 diabetes mellitus treated with oral hypoglycemic agents: a retrospective claims data analysis.

Bron M, Guerin A, Latremouille-Viau D, Ionescu-Ittu R, Viswanathan P, Lopez C, Wu EQ. Bron M, et al. J Med Econ. 2014 Sep;17(9):646-57. doi: 10.3111/13696998.2014.925905. Epub 2014 Jun 24. J Med Econ. 2014. PMID: 24959693 Free article.

4

Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab-carboplatin-paclitaxel and carboplatin-paclitaxel: a retrospective cohort study.

Langer C, Ravelo A, Hazard SJ, Guerin A, Ionescu-Ittu R, Latremouille-Viau D, Wu EQ, Ramalingam S. Langer C, et al. Lung Cancer. 2014 Dec;86(3):350-7. doi: 10.1016/j.lungcan.2014.09.017. Epub 2014 Sep 30. Lung Cancer. 2014. PMID: 25439437

5

Psoriasis and risk of diabetes-associated microvascular and macrovascular complications.

Armstrong AW, Guérin A, Sundaram M, Wu EQ, Faust ES, Ionescu-Ittu R, Mulani P. Armstrong AW, et al. J Am Acad Dermatol. 2015 Jun;72(6):968-77.e2. doi: 10.1016/j.jaad.2015.02.1095. Epub 2015 Mar 17. J Am Acad Dermatol. 2015. PMID: 25791800

6

Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice.

Gallagher CM, More K, Masaquel A, Kamath T, Guerin A, Ionescu-Ittu R, Nitulescu R, Gauthier-Loiselle M, Sicignano N, Butts E, Wu EQ, Barnett B. Gallagher CM, et al. Springerplus. 2016 Mar 31;5:395. doi: 10.1186/s40064-016-2008-9. eCollection 2016. Springerplus. 2016. PMID: 27047721 Free PMC article.

7

Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer.

Gallagher CM, More K, Kamath T, Masaquel A, Guerin A, Ionescu-Ittu R, Gauthier-Loiselle M, Nitulescu R, Sicignano N, Butts E, Wu EQ, Barnett B. Gallagher CM, et al. Breast Cancer Res Treat. 2016 May;157(1):145-56. doi: 10.1007/s10549-016-3790-3. Epub 2016 Apr 23. Breast Cancer Res Treat. 2016. PMID: 27107569 Free PMC article.

8

Overall Survival in Patients with HER2+ Early Stage Breast Cancer Patients Treated with Trastuzumab in the US Department of Defense Practice Setting.

Gallagher CM, More K, Masaquel AS, Kamath T, Guerin A, Ionescu-Ittu R, Gauthier-Loiselle M, Nitulescu R, Sicignano N, Barnett B, Wu EQ. Gallagher CM, et al. Value Health. 2014 Nov;17(7):A615. doi: 10.1016/j.jval.2014.08.2164. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202155 Free article. No abstract available.

9

Overall survival in patients with glioblastoma before and after bevacizumab approval.

Johnson DR, Omuro AMP, Ravelo A, Sommer N, Guerin A, Ionescu-Ittu R, Shi S, Macalalad A, Uhm JH. Johnson DR, et al. Curr Med Res Opin. 2018 May;34(5):813-820. doi: 10.1080/03007995.2017.1392294. Epub 2017 Nov 10. Curr Med Res Opin. 2018. PMID: 29025274

10

Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy.

Borghaei H, Yim YM, Guerin A, Pivneva I, Shi S, Gandhi M, Ionescu-Ittu R. Borghaei H, et al. Lung Cancer. 2018 May;119:112-119. doi: 10.1016/j.lungcan.2018.02.011. Epub 2018 Feb 21. Lung Cancer. 2018. PMID: 29656745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters